Short and Long-term Effects of Adding Oral L-arginine to Standard Therapy in Patients With COVID-19 (SARS-CoV-2)
NCT04637906
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
290
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Interventions
DIETARY_SUPPLEMENT:
Bioarginina®
Sponsor
University of Campania Luigi Vanvitelli